oxybutynin has been researched along with Ischemic Stroke in 2 studies
oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.
Ischemic Stroke: Stroke due to BRAIN ISCHEMIA resulting in interruption or reduction of blood flow to a part of the brain. When obstruction is due to a BLOOD CLOT formed within in a cerebral blood vessel it is a thrombotic stroke. When obstruction is formed elsewhere and moved to block a cerebral blood vessel (see CEREBRAL EMBOLISM) it is referred to as embolic stroke. Wake-up stroke refers to ischemic stroke occurring during sleep while cryptogenic stroke refers to ischemic stroke of unknown origin.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Men with locally advanced or metastatic prostate cancer were randomly allocated (1:2 from August, 2007 then 1:1 from February, 2011) to either LHRHa according to local practice or tE2 patches (four 100 μg patches per 24 h, changed twice weekly, reducing to three patches twice weekly if castrate at 4 weeks [defined as testosterone ≤1·7 nmol/L])." | 3.01 | Transdermal oestradiol for androgen suppression in prostate cancer: long-term cardiovascular outcomes from the randomised Prostate Adenocarcinoma Transcutaneous Hormone (PATCH) trial programme. ( Alhasso, A; Clarke, NW; Collins, GN; Deighan, JV; Dixit, S; Duong, T; Forcat, S; Gilbert, DC; Kockelbergh, R; Kynaston, H; Langley, RE; Laniado, ME; Macnair, A; Madaan, S; Manetta, C; Mangar, S; Marshall, J; McFarlane, J; Mckay, S; Muazzam, IA; Nankivell, M; Paez, E; Parmar, M; Pope, A; Robinson, A; Rosen, SD; Scrase, CD; Sundaram, SK; Weiss, M; Williams, ST; Worlding, J, 2021) |
| " GTN appears safe in ipsilateral or bilateral carotid stenosis, and might improve outcome in severe ipsilateral carotid stenosis." | 2.90 | It is safe to use transdermal glyceryl trinitrate to lower blood pressure in patients with acute ischaemic stroke with carotid stenosis. ( Appleton, JP; Bath, PM; Belcher, A; Bereczki, D; Berge, E; Caso, V; Chang, HM; Christensen, HK; Collins, R; Gommans, J; Laska, AC; Ntaios, G; Ozturk, S; Sare, GM; Sprigg, N; Szatmari, S; Wang, Y; Wardlaw, JM; Woodhouse, LJ, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Langley, RE | 1 |
| Gilbert, DC | 1 |
| Duong, T | 1 |
| Clarke, NW | 1 |
| Nankivell, M | 1 |
| Rosen, SD | 1 |
| Mangar, S | 1 |
| Macnair, A | 1 |
| Sundaram, SK | 1 |
| Laniado, ME | 1 |
| Dixit, S | 1 |
| Madaan, S | 1 |
| Manetta, C | 1 |
| Pope, A | 1 |
| Scrase, CD | 1 |
| Mckay, S | 1 |
| Muazzam, IA | 1 |
| Collins, GN | 1 |
| Worlding, J | 1 |
| Williams, ST | 1 |
| Paez, E | 1 |
| Robinson, A | 1 |
| McFarlane, J | 1 |
| Deighan, JV | 1 |
| Marshall, J | 1 |
| Forcat, S | 1 |
| Weiss, M | 1 |
| Kockelbergh, R | 1 |
| Alhasso, A | 1 |
| Kynaston, H | 1 |
| Parmar, M | 1 |
| Appleton, JP | 1 |
| Woodhouse, LJ | 1 |
| Belcher, A | 1 |
| Bereczki, D | 1 |
| Berge, E | 1 |
| Caso, V | 1 |
| Chang, HM | 1 |
| Christensen, HK | 1 |
| Collins, R | 1 |
| Gommans, J | 1 |
| Laska, AC | 1 |
| Ntaios, G | 1 |
| Ozturk, S | 1 |
| Sare, GM | 1 |
| Szatmari, S | 1 |
| Wang, Y | 1 |
| Wardlaw, JM | 1 |
| Sprigg, N | 1 |
| Bath, PM | 1 |
2 trials available for oxybutynin and Ischemic Stroke
| Article | Year |
|---|---|
Transdermal oestradiol for androgen suppression in prostate cancer: long-term cardiovascular outcomes from the randomised Prostate Adenocarcinoma Transcutaneous Hormone (PATCH) trial programme.
Topics: Acute Coronary Syndrome; Adenocarcinoma; Aged; Aged, 80 and over; Androgen Antagonists; Embolic Stro | 2021 |
It is safe to use transdermal glyceryl trinitrate to lower blood pressure in patients with acute ischaemic stroke with carotid stenosis.
Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Antihypertensive Agents; Blood Pressure; Carotid | 2019 |